Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |